AK9
Basic information
Region (hg38): 6:109492855-109691217
Previous symbols: [ "C6orf224", "AKD2", "C6orf199", "AKD1" ]
Links
Phenotypes
GenCC
Source:
- postsynaptic congenital myasthenic syndrome (Supportive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Spermatogenic failure 89 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Genitourinary | 37713809 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the AK9 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 9 | |||||
missense | 77 | 84 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 3 | 3 | ||||
non coding | 3 | |||||
Total | 0 | 0 | 78 | 7 | 11 |
Variants in AK9
This is a list of pathogenic ClinVar variants found in the AK9 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-109493382-G-T | not specified | Uncertain significance (Nov 09, 2022) | ||
6-109493386-C-A | not specified | Uncertain significance (Sep 01, 2021) | ||
6-109493551-C-T | not specified | Uncertain significance (Nov 03, 2022) | ||
6-109494025-C-T | not specified | Uncertain significance (Oct 02, 2023) | ||
6-109495375-A-C | not specified | Uncertain significance (May 14, 2024) | ||
6-109495381-G-A | not specified | Uncertain significance (Oct 18, 2021) | ||
6-109495427-A-T | not specified | Uncertain significance (Mar 31, 2024) | ||
6-109497503-A-G | Benign (May 09, 2018) | |||
6-109497537-A-G | not specified | Uncertain significance (Mar 15, 2024) | ||
6-109497859-C-T | not specified | Uncertain significance (Aug 21, 2023) | ||
6-109497896-T-G | not specified | Uncertain significance (Feb 05, 2024) | ||
6-109497932-G-A | not specified | Uncertain significance (Feb 02, 2022) | ||
6-109499129-A-G | not specified | Uncertain significance (May 20, 2024) | ||
6-109499186-C-T | not specified | Uncertain significance (Oct 04, 2022) | ||
6-109499194-C-T | Benign (Feb 26, 2018) | |||
6-109499214-A-ATAAC | Spermatogenic failure 89 | Pathogenic (Feb 05, 2024) | ||
6-109499227-G-A | Benign (Mar 01, 2023) | |||
6-109499235-C-T | not specified | Uncertain significance (Jun 02, 2023) | ||
6-109506403-C-A | Benign (Oct 09, 2017) | |||
6-109506491-T-C | not specified | Uncertain significance (Dec 17, 2023) | ||
6-109506526-A-G | Benign (Apr 30, 2018) | |||
6-109506531-G-A | not specified | Uncertain significance (Mar 07, 2024) | ||
6-109506743-C-A | not specified | Uncertain significance (Apr 27, 2023) | ||
6-109506757-G-T | not specified | Uncertain significance (May 26, 2024) | ||
6-109509278-A-G | not specified | Uncertain significance (Jun 29, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
AK9 | protein_coding | protein_coding | ENST00000424296 | 40 | 198362 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.69e-26 | 1.00 | 125607 | 0 | 141 | 125748 | 0.000561 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.19 | 725 | 911 | 0.795 | 0.0000445 | 12605 |
Missense in Polyphen | 259 | 308.46 | 0.83965 | 4256 | ||
Synonymous | 2.34 | 254 | 306 | 0.830 | 0.0000152 | 3325 |
Loss of Function | 3.71 | 57 | 96.3 | 0.592 | 0.00000453 | 1418 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00134 | 0.00134 |
Ashkenazi Jewish | 0.00129 | 0.00129 |
East Asian | 0.000283 | 0.000272 |
Finnish | 0.000237 | 0.000231 |
European (Non-Finnish) | 0.000501 | 0.000492 |
Middle Eastern | 0.000283 | 0.000272 |
South Asian | 0.000673 | 0.000621 |
Other | 0.00102 | 0.000978 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in maintaining the homeostasis of cellular nucleotides by catalyzing the interconversion of nucleoside phosphates. Has both nucleoside monophosphate and diphosphate kinase activities. Catalyzes the phosphorylation of AMP, dAMP, CMP and dCMP with ATP as phosphate donor and of CMP with GTP as phosphate donor. Also catalyzes the production of ATP, CTP, GTP, UTP, dATP, dCTP, dGTP and TTP from the corresponding diphosphate substrates with either ATP or GTP as phosphate donor. Shows substrate preference of CDP > UDP > ADP > GDP > TDP. {ECO:0000269|PubMed:23416111}.;
- Pathway
- Pyrimidine metabolism - Homo sapiens (human);Purine metabolism - Homo sapiens (human);Metabolism of nucleotides;Interconversion of nucleotide di- and triphosphates;Metabolism
(Consensus)
Recessive Scores
- pRec
- 0.0711
Intolerance Scores
- loftool
- rvis_EVS
- 1.72
- rvis_percentile_EVS
- 96.5
Haploinsufficiency Scores
- pHI
- 0.207
- hipred
- N
- hipred_score
- 0.195
- ghis
- 0.472
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Ak9
- Phenotype
Zebrafish Information Network
- Gene name
- ak9
- Affected structure
- otolith
- Phenotype tag
- abnormal
- Phenotype quality
- morphology
Gene ontology
- Biological process
- dADP phosphorylation;dGDP phosphorylation;AMP phosphorylation;ATP generation from ADP;nucleobase-containing small molecule interconversion;CDP phosphorylation;dAMP phosphorylation;CMP phosphorylation;dCMP phosphorylation;GDP phosphorylation;UDP phosphorylation;dCDP phosphorylation;TDP phosphorylation
- Cellular component
- nucleus;nucleoplasm;cytoplasm;cytosol;nuclear membrane
- Molecular function
- nucleoside diphosphate kinase activity;ATP binding;nucleoside kinase activity;nucleoside monophosphate kinase activity